Alternative

Response Biomedical Corp. Schedules Third Quarter 2013 Earnings Release and Conference Call and Announces Participation in Upcoming Investor Conferences

VANCOUVER, BRITISH COLUMBIA: ...

New StrixNB(TM) Pet Oral Care Approval from Heath Canada's LRVHP Program

WINNIPEG, MANITOBA: ...

Fuzheng Huayu (FZHY) Completed Phase II Clinical Trial for Treatment of Liver Fibrosis in Patients With Chronic Hepatitis C

SHANGHAI, CHINA: The Botanical Compound Achieves a Major Milestone in Drug Development in the US ...

EnWave Signs Agency Agreement with CD Process LLC

VANCOUVER, BRITISH COLUMBIA: ...

Nuvilex, Inc. Reaches Unofficial Starting Line of Its Phase 3 Pancreatic Cancer Clinical Trials

NEW YORK, NY: ...

Allerayde SAB Retains Investor Communication Firm

LONDON, UNITED KINGDOM: ...

Easton Pharmaceuticals Is Provided a Manufacturing, Regulatory Filing Update and Forward Sales Estimates for VIORRA

TORONTO, ON: ...

MedStar Health Announces New Board Leadership

COLUMBIA, MD: ...

Is Nuvilex Ready to Acquire Diabetes Technology and Control Cancer and Diabetes Cell Encapsulation Markets?

NEW YORK, NY: ...

Vycor's NovaVision(R) Vision Restoration Therapy Awarded New Patent

BOCA RATON, FL: Company Re-Engineering VRT(TM) to Allow For Delivery of Therapy via the Internet ...